Pilot Therapeutics Holdings Inc.
PLTT
$0.0001
$0.000.00%
OTC PK
| 06/30/2003 | 03/31/2003 | 12/31/2002 | 09/30/2002 | 06/30/2002 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -29.89% | -34.44% | -17.77% | 114.43% | 402.75% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -39.20% | -41.83% | -25.31% | 81.42% | 207.10% |
| Operating Income | 39.20% | 41.83% | 25.31% | -81.42% | -207.10% |
| Income Before Tax | 32.97% | 33.02% | 13.62% | -94.75% | -218.15% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 32.97% | 33.02% | 13.62% | -94.75% | -218.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 32.97% | 33.02% | 13.62% | -94.75% | -218.15% |
| EBIT | 39.20% | 41.83% | 25.31% | -81.42% | -207.10% |
| EBITDA | 39.24% | 42.00% | 25.46% | -82.38% | -209.16% |
| EPS Basic | 42.06% | 42.58% | 26.74% | 29.34% | 44.43% |
| Normalized Basic EPS | 41.36% | 40.90% | 22.76% | 26.66% | 44.29% |
| EPS Diluted | 42.06% | 42.58% | 26.74% | 29.34% | 44.43% |
| Normalized Diluted EPS | 41.36% | 40.90% | 22.76% | 26.66% | 44.29% |
| Average Basic Shares Outstanding | 12.59% | 12.93% | 13.23% | 41.45% | 97.08% |
| Average Diluted Shares Outstanding | 12.59% | 12.93% | 13.23% | 41.45% | 97.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |